021-51111890
购物车（）
sales@molnova.cn
I-BET762
CAS No. 1260907-17-2
I-BET762 ( GSK525762A;GSK-525762A;I-BET-762;Molibresib )
产品货号. M11080 CAS No. 1260907-17-2
I-BET762 (GSK-525762A, Molibresib) is a highly potent, selective inhibitor of BET family proteins.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥421 | 有现货 |
|
| 5MG | ￥689 | 有现货 |
|
| 10MG | ￥1029 | 有现货 |
|
| 25MG | ￥1847 | 有现货 |
|
| 50MG | ￥3054 | 有现货 |
|
| 100MG | ￥4560 | 有现货 |
|
| 200MG | ￥6415 | 有现货 |
|
| 500MG | ￥9963 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称I-BET762
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述I-BET762 (GSK-525762A, Molibresib) is a highly potent, selective inhibitor of BET family proteins.
-
产品描述I-BET762 (GSK-525762A, Molibresib) is a highly potent, selective inhibitor of BET family proteins BRD2, BRD3 and BRD4 with IC50 of 32.5-42.5 nM, does not interact with other bromodomain-containing proteins (BAZ2B, ATAD2, CREBBP and PCAF); inhibits binding of BET proteins to acetylated histones, disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, suppresses TNF-inducible key proinflammatory cytokine (il1b, il1a) and chemokine genes (ccl5, cxcl10, cxcl2/3) in BMDMs; inhibits the ability of Th1-differentiated 2D2 T cells to induce neuroinflammation in vivo in mouse model of EAE; inhibits myeloma cell proliferation both in vitro and myeloma xenograft models.Blood Cancer Phase 2 Clinical
-
同义词GSK525762A;GSK-525762A;I-BET-762;Molibresib
-
通路Chromatin/Epigenetic
-
靶点Bromodomain
-
受体BETproteins
-
研究领域Cancer
-
适应症Blood cancer
化学信息
-
CAS Number1260907-17-2
-
分子量423.90
-
分子式C22H22ClN5O2
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(NCC)C[C@H]1C2=NN=C(C)N2C3=CC=C(OC)C=C3C(C4=CC=C(Cl)C=C4)=N1
-
化学全称4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-, (4S)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Nicodeme E, et al. Nature. 2010 Dec 23;468(7327):1119-23.
2. Bandukwala HS, et al. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14532-7.
3. Mirguet O, et al. J Med Chem. 2013 Oct 10;56(19):7501-15.
4. Chaidos A, et al. Blood. 2014 Jan 30;123(5):697-705.
2. Bandukwala HS, et al. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14532-7.
3. Mirguet O, et al. J Med Chem. 2013 Oct 10;56(19):7501-15.
4. Chaidos A, et al. Blood. 2014 Jan 30;123(5):697-705.
产品手册
关联产品
-
BI 894999
BI 894999 is a novel potent, selective BET inhibitor with IC50 of 5 and 41 nM for BRD4-BD1 and BRD4-BD2 bromodomains, respectively.
-
JQ1
(+)-JQ-1 (JQ1) is a potent, selective, cell-permeable BET bromodomain inhibitor with IC50 of 77 nM/33 nM for BRD4 BD1 and BD2, respectively.
-
BAY 299
BAY 299 is a potent and selective inhibitor of the bromodomain and PHD finger-containing (BRPF) family protein BRD1 and the second bromodomain of TAF1 with IC50 of 6 nM and 13 nM, respectively.
